Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)

Market Cap	9.23B
Revenue (ttm)	2.52B
Net Income (ttm)	293.97M
Shares Out	584.00M
EPS (ttm)	0.50
PE Ratio	31.38
Forward PE	n/a
Dividend	0.50 (3.17%)
Ex-Dividend Date	Jun 14, 2024

Volume	2,950,417
Average Volume	4,120,293
Open	15.90
Previous Close	15.75
Day's Range	15.65 - 15.90
52-Week Range	15.50 - 30.68
Beta	0.33
RSI	36.64
Earnings Date	Aug 28, 2025

About SHE:002737

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children’s medicinal products. The company sells its products under ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 5,727
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002737

Financial Performance

In 2024, SHE:002737's revenue was 3.38 billion, a decrease of -40.76% compared to the previous year's 5.70 billion. Earnings were 492.05 million, a decrease of -56.03%.